Affiliation:
1. Division of Gastroenterology, Department of Internal Medicine, Mubarak Alkabeer University Hospital, Jabriya 47060, Kuwait
2. Department of Biochemistry and Molecular Biology, Dasman Diabetes Institute, Dasman 15462, Kuwait
Abstract
Introduction: Patients with inflammatory bowel disease (IBD) on biologic therapies are at increased risk of infections, emphasizing the importance of immunization. This study aimed to assess vaccination prevalence among patients with IBD on specific biologic therapies. Methods: A survey-based cross-sectional study was conducted at an IBD center, including patients receiving different biologic therapies from 1 January 2022 to the 30 April 2023. Demographic and vaccination data were collected using patient electronic records and patient interviews. Results: A total 394 patients (100%) received the measles, mumps, rubella (MMR), tetanus, reduced diphtheria, and acellular pertussis (Tdap) vaccine. A total of 79 patients (20%) received the influenza vaccine, 40 patients (10.2%) were vaccinated against hepatitis A (HAV), and 34 patients (8.6%) received the pneumococcal vaccine. From the 103 female patients who are eligible to take human papillomavirus (HPV) vaccine, only 7 (6.8%) received it. Out of the 100 eligible patients above the age of 50, only 9 (9%) received the herpes zoster (HZ) vaccine. Conclusion: The uptake of certain vaccines such as Hepatitis B (HBV), seasonal influenza, HAV, pneumococcal, HZ and HPV vaccines among patients with IBD were below expectations. These findings highlight the need for interventions to improve patients’ awareness and adherence to prevent infectious complications in patients with IBD.
Subject
Gastroenterology,Hepatology
Reference48 articles.
1. García-Serrano, C., Mirada, G., Marsal, J.R., Ortega, M., Sol, J., Solano, R., Artigues, E.M., and Estany, P. (2020). Compliance with the guidelines on recommended immunization schedule in patients with inflammatory bowel disease: Implications on public health policies. BMC Public Health, 20.
2. Incidence, prevalence, and clinical epidemiology of inflammatory bowel disease in the Arab World: A systematic review and meta-analysis;Mosli;Inflamm. Intest. Dis.,2021
3. Inflammatory bowel disease: Clinical aspects and treatments;Fakhoury;J. Inflamm. Res.,2014
4. DiPiro, J.T., Talbert, R.L., Yee, G.C., Matzke, G.R., Wells, B.G., and Posey, L.M. (2017). Pharmacotherapy: A Pathophysiologic Approach, McGraw-Hill Education. [10th ed.]. Hemstreet BAInflammatory Bowel Disease.
5. The diagnosis of intra-abdominal abscesses in patients with severe Crohn’s disease;Wheeler;QJM Int. J. Med.,1992
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献